PL1794189T3 - Hydrolizaty z serwatki hamujące ACE - Google Patents

Hydrolizaty z serwatki hamujące ACE

Info

Publication number
PL1794189T3
PL1794189T3 PL05774775T PL05774775T PL1794189T3 PL 1794189 T3 PL1794189 T3 PL 1794189T3 PL 05774775 T PL05774775 T PL 05774775T PL 05774775 T PL05774775 T PL 05774775T PL 1794189 T3 PL1794189 T3 PL 1794189T3
Authority
PL
Poland
Prior art keywords
ace
inhibitory
relates
hydrolysates
angiotensin
Prior art date
Application number
PL05774775T
Other languages
English (en)
Inventor
Slegte Jaap De
Gijsbertus Klarenbeek
Original Assignee
Friesland Brands Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Friesland Brands Bv filed Critical Friesland Brands Bv
Publication of PL1794189T3 publication Critical patent/PL1794189T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4717—Plasma globulins, lactoglobulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/15—Peptidyl-dipeptidases (3.4.15)
    • C12Y304/15001—Peptidyl-dipeptidase A (3.4.15.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21026—Prolyl oligopeptidase (3.4.21.26), i.e. proline-specific endopeptidase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
PL05774775T 2004-08-31 2005-08-29 Hydrolizaty z serwatki hamujące ACE PL1794189T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL1026931A NL1026931C2 (nl) 2004-08-31 2004-08-31 ACE-remmende wei-hydrolysaten.
EP05774775A EP1794189B1 (en) 2004-08-31 2005-08-29 Ace-inhibitory whey hydrolysates
PCT/NL2005/000622 WO2006025731A1 (en) 2004-08-31 2005-08-29 Ace-inhibitory whey hydrolysates

Publications (1)

Publication Number Publication Date
PL1794189T3 true PL1794189T3 (pl) 2008-12-31

Family

ID=34974250

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05774775T PL1794189T3 (pl) 2004-08-31 2005-08-29 Hydrolizaty z serwatki hamujące ACE

Country Status (11)

Country Link
US (1) US20080070828A1 (pl)
EP (1) EP1794189B1 (pl)
JP (1) JP2008511317A (pl)
AT (1) ATE397623T1 (pl)
DE (1) DE602005007365D1 (pl)
DK (1) DK1794189T3 (pl)
ES (1) ES2308531T3 (pl)
NL (1) NL1026931C2 (pl)
PL (1) PL1794189T3 (pl)
PT (1) PT1794189E (pl)
WO (1) WO2006025731A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1967524A1 (en) * 2007-03-06 2008-09-10 Friesland Brands B.V. Methods for producing ACE-inhibitory peptides from whey and peptides obtained thereby
US20110130637A1 (en) * 2008-03-20 2011-06-02 University Of Dundee Protein product for modifying cardiovascular health
DE102008032828A1 (de) 2008-07-02 2010-01-07 Technische Universität Dresden Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel
DE102011005288B4 (de) 2011-03-09 2018-10-11 Technische Universität Dresden Verfahren zur Herstellung eines Proteinhydrolysats mit ACE-hemmenden tryptophanhaltigen Dipeptiden
ES2394988B2 (es) * 2011-06-15 2013-06-06 Queizúar, S.L. Procedimiento optimizado para la obtención de péptidos inhibidores de la actividad de la eca a partir de suero lácteo, péptidos inhibidores de la eca y alimento que los comprende.
CN103215331A (zh) * 2013-04-16 2013-07-24 陕西科技大学 一种复合酶解羊乳酪蛋白制备ace抑制肽的方法
CN103215333A (zh) * 2013-04-16 2013-07-24 陕西科技大学 一种酶解羊乳酪蛋白制备ace抑制肽的方法
CN112574294A (zh) * 2020-12-30 2021-03-30 青海瑞肽生物科技有限公司 一种胶原蛋白肽及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1287159A4 (en) * 2000-05-08 2005-02-09 Davisco Foods Int Inc Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals
ATE475324T1 (de) * 2000-12-07 2010-08-15 Dsm Ip Assets Bv Mit carboxy-terminal prolin peptide angereicherte proteinhydrolysate
RU2292155C2 (ru) * 2001-07-18 2007-01-27 ДСМ Ай Пи ЭССЕТС Б.В. Способ гидролиза молочных белков
AU2003210741A1 (en) * 2002-01-30 2003-09-02 The Cleveland Clinic Foundation Ptpase inhibitors and methods of using the same

Also Published As

Publication number Publication date
ATE397623T1 (de) 2008-06-15
EP1794189B1 (en) 2008-06-04
ES2308531T3 (es) 2008-12-01
NL1026931C2 (nl) 2006-03-01
DE602005007365D1 (de) 2008-07-17
DK1794189T3 (da) 2008-09-15
EP1794189A1 (en) 2007-06-13
PT1794189E (pt) 2008-09-10
US20080070828A1 (en) 2008-03-20
WO2006025731A1 (en) 2006-03-09
JP2008511317A (ja) 2008-04-17

Similar Documents

Publication Publication Date Title
WO2008108649A3 (en) Ace-inhibitory peptides from whey and methods for providing the same.
Otte et al. Angiotensin-converting enzyme inhibitory activity of milk protein hydrolysates: Effect of substrate, enzyme and time of hydrolysis
Gazme et al. Occurrence, properties and biological significance of pyroglutamyl peptides derived from different food sources
WO2005118620A3 (en) Methods for preparing internally constraied peptides and peptidomimetics
Miguel et al. Changes in arterial blood pressure after single oral administration of milk‐casein‐derived peptides in spontaneously hypertensive rats
JP2010520274A5 (pl)
WO2008066583A3 (en) Cell-free synthesis of proteins containing unnatural amino acids
EP1908773B8 (en) Process for producing dipeptides
PL1794189T3 (pl) Hydrolizaty z serwatki hamujące ACE
WO2003070892A3 (en) Inhibitors of rgs proteins
Cao et al. Purification and identification of an ACE inhibitory peptide from the peptic hydrolysate of Acetes chinensis and its antihypertensive effects in spontaneously hypertensive rats
CA2567582A1 (en) Anti-hypertensive dietary supplement derived from salmo or oncorhynchus protein hydrolysates
AU2003217325A1 (en) Complex technologies using enzymatic protein hydrolysate
TWI268138B (en) Composition containing peptide and electrolyte excretion enhancing substance, and food containing the same
AU2003303424A1 (en) Method and system for recognizing call switch-over from 1xev-do system to 1x system
WO2007053390A3 (en) Methods for the use of branched chain amino acids
WO2004039174A3 (en) A method of preventing acrylamide formation in a foodstuff
WO2008146259A3 (en) Malt1 specific cleavage in assay and screening method
WO2004085664A3 (en) Process for the preparation of angiotensin converting enzyme (ace) inhibitors and its use
EP1529837A3 (en) Microorganisms producing dipeptides and process for producing dipeptides using the microorganisms
AU2003248117A1 (en) Novel enzyme forming peptide, microorganism producing the same and process for producing dipeptide using them
WO2003070229A3 (de) Verwendung von proteinaseinhibitoren zur behandlung von autoimmunerkrankungen
WO2004019965A3 (en) Thymus-based tolerogenic approaches for type i diabetes.
MXPA05011783A (es) Peptidos que tienen un efecto inhibidor de enzima convertidora de angiotensina.
WO2005071067A3 (en) Non-animal origin stabilizers and processes for producing the same